Hepatitis B virus biology

Microbiology and Molecular Biology Reviews

Volumn 64, Issue 1, 2000, Pages 51-68

  Seeger, Christoph ^a   Mason, William S ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS PROTEIN;

HEPADNAVIRUS; HEPATITIS B; HEPATITIS B VIRUS; LIVER CANCER; NONHUMAN; REVERSE TRANSCRIPTION; REVIEW; VIROLOGY; VIRUS ASSEMBLY; VIRUS EXPRESSION; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

DNA VIRUSES; HEPADNAVIRIDAE; HEPATITIS B VIRUS;

EID: 0034057803     PISSN: 10922172     EISSN: None     Source Type: Journal    
DOI: 10.1128/MMBR.64.1.51-68.2000     Document Type: Review

References (255)

1. Albritton, L. M., L. Tseng, D. Scadden, and J. M. Cunningham. 1989. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57:659-666.
2. Aldrich, C. E., L. Coates, T. T. Wu, J. Newbold, B. C. Tennant, J. Summers, C. Seeger, and W. S. Mason. 1989. In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus. Virology 172:247-252.
3. Allen, M. I., M. Deslauriers, C. W. Andrews, G. A. Tipples, K. A. Walters, D. L. Tyrrell, N. Brown, and L. D. Condreay. 1998. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 27:1670-1677.
4. Balsano, C., M. L. Avantaggiati, G. Natoli, M. E. De, H. Will, M. Perricaudet, and M. Levrero. 1991. Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level. Biochem. Biophys. Res. Commun. 176: 985-992.
5. Barker, L. F., F. V. Chisari, P. P. McGrath, D. W. Dalgard, R. L. Kirschstein, J. D. Almeida, T. S. Edgington, D. G. Sharp, and M. R. Peterson. 1973. Transmission of type B viral hepatitis to chimpanzees. J. Infect. Dis. 127:648-652.
6. Bartenschlager, R., M. Junker-Niepmann, and H. Schaller. 1990. The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J. Virol. 64:5324-5332.
7. Bartenschlager, R., and H. Schaller. 1992. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J. 11:3413-3420.
8. Bartholomeusz, A., L. C. Groenen, and S. A. Locarnini. 1997. Clinical experience with famciclovir against hepatitis B virus. Intervirology 40:337-342.
9. Bartholomew, M. M., R. W. Jansen, L. J. Jeffers, K. R. Reddy, L. C. Johnson, H. Bunzendahl, L. D. Condreay, A. G. Tzakis, E. R. Schiff, and N. A. Brown. 1997. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 349:20-22.
10. Beasley, R. 1988. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 61:1942-1956.
11. Beasley, R. P. 1982. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic considerations. Hepatology 2:21S-26S.
12. Beasley, R. P., and L.-Y. Hwang. 1991. Overview on the epidemiology of hepatocellular carcinoma, p. 532-535. In F. B. Hollinger, S. M. Lemon, and H. S. Margolis (ed.), Viral hepatitis and liver disease. The Williams & Wilkins Co., Baltimore, Md.
13. Beckel-Mitchener, A., and J. Summers. 1997. A novel transcriptional element in circular DNA monomers of the duck hepatitis B virus. J. Virol. 71:7917-7922.
14. Benn, J., and R. J. Schneider. 1994. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc. Natl. Acad. Sci. USA 91:10350-10354.
15. Berquist, K. R., J. M. Peterson, B. L. Murphy, J. W. Ebert, J. E. Maynard, and R. H. Purcell. 1975. Hepatitis B antigens in serum and liver of chimpanzees acutely infected with hepatitis B virus. Infect. Immun. 12:602-605.
16. Blum, H. E., A. P. Geballe, L. Stowring, A. Figus, A. Haase, and G. Vyas. 1984. Hepatitis B virus in nonhepatocytes: demonstration of viral DNA in spleen, bile duct epithelium, and vascular elements by in situ hybridization, p. 634. In G. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle (ed.), Viral hepatitis and liver disease. Grune & Stratton, New York, N.Y.
17. Blum, H. E., Z. S. Zhang, E. Galun, W. F. von, B. Garner, T. J. Liang, and J. R. Wands. 1992. Hepatitis B virus X protein is not central to the viral life cycle in vitro. J. Virol. 66:1223-1227.
18. Borel, C., C. Sunyach, O. Hantz, C. Trepo, and A. Kay. 1998. Phosphorylation of DHBV pre-S: identification of the major site of phosphorylation and effects of mutations on the virus life cycle. Virology 242:90-98.
19. Bottcher, B., S. A. Wynne, and R. A. Crowther. 1997. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 386:88-91.
20. Brechet, C., C. Pourcel, A. Louise, B. Rain, and P. Tiollais. 1980. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286:533-535.
21. Bressac, B., M. Kew, J. Wands, and M. Ozturk. 1991. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431.
22. Brook, M. G., P. Karayiannis, and H. C. Thomas. 1989. Which patients with chronic hepatitis B virus infection will respond to a-interferon therapy? A statistical analysis of predictive factors. Hepatology 10:761-763.
23. Brass, V., J. Hagelstein, E. Gerhardt, and P. R. Galle. 1996. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. Virology 218:396-409.
24. Bruss, V., X. Lu, R. Thomssen, and W. H. Gerlich. 1994. Post-translational alterations in transmemhrane topology of the hepatitis B virus large envelope protein. EMBO J. 13:2273-2279.
25. Buetow, K. H., V. C. Sheffield, M. Zhu, T. Zhou, F. M. Shen, O. Hino, M. Smith, B. J. McMahon, A. P. Lanier, W. T. London, et al. 1992. Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 89:9622-9626.
26. Cavanaugh, V. J., L. Guidotti, and F. V. Chisari. 1998. Inhibition of Hepatitis B virus replication during adenovirus and cytomegalovirus infections with transgenic mice. J. Virol. 72:2630-2637.
27. Chakraborty, P. R., N. Ruiz-Opazo, D. Shouval, and D. A. Shafritz. 1980. Identification of integrated hepatitis B virus DNA and expression of viral RNA in HBsAg-producing human hepatocellular carcinoma cell line. Nature 286:531-533.
28. Chang, C., G. Enders, R. Sprengel, N. Peters, H. E. Varmus, and D. Ganem. 1987. Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J. Virol. 61:3322-3325.
29. Chang, C., S. Zhou, D. Ganem, and D. N. Standring. 1994. Phenotypic mixing between different hepadnavirus nucleocapsid proteins reveals C protein dimerization to be cis preferential. J. Virol. 68:5225-5231.
30. Chang, L. J., P. Pryciak, D. Ganem, and H. E. Varmus. 1989. Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribosomal frameshifting. Nature 337:364-368.
31. Chayama, K., Y. Suzuki, M. Kobayashi, A. Tsubota, M. Hashimoto, Y. Miyano, H. Koike, I. Koida, Y. Arase, S. Saitoh, N. Murashima, K. Ikeda, and H. Kumada. 1998. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology 27:1711-1716.
32. Chen, H. S., S. Kaneko, R. Girones, R. W. Anderson, W. E. Hornbuckle, B. C. Tennant, P. J. Cote, J. L. Gerin, R. H. Purcell, and R. H. Miller. 1993. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J. Virol. 67:1218-1226.
33. Chen, H. S., M. C. Kew, W. E. Hornbuckle, B. C. Tennant, P. J. Cote, J. L. Gerin, R. H. Purcell, and R. H. Miller. 1992. The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host. J. Virol. 66:5682-5684.
34. Chisari, F. V., K. Klopchin, T. Moriyama, C. Pasquinelli, H. A. Dunsford, S. Sell, C. A. Pinkert, R. L. Brinster, and R. D. Palmiter. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145-1156.
35. Civitico, G. M., and S. A. Locarnini. 1994. The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures. Virology 203:81-89.
36. Coleman, W. B., A. E. Wennerberg, G. J. Smith, and J. W. Grisham. 1993. Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stemlike) cells by the hepatic microenvironment. Am. J. Pathol. 142:1373-1382.
37. Colgrove, R., G. Simon, and D. Ganem. 1989. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J. Virol. 63:4019-4026.
38. Conway, J. F., N. Cheng, A. Zlotnick, S. J. Stahl, P. T. Wingfield, D. M. Belnap, U. Kanngiesser, M. Noah, and A. C. Steven. 1998. Hepatitis B virus capsid: localization of the putative immunodominant loop (residues 78 to 83) on the capsid surface, and implications for the distinction between c-and e-antigens. J. Mol. Biol. 279:1111-1121.
39. Conway, J. F., N. Cheng, A. Zlotnick, P. T. Wingfield, S. J. Stahl, and A. C. Steven. 1997. Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature 386:91-94.
40. Crescenzo-Chaigne, B., J. Pillot, and A. Lilienbaum. 1995. Interplay between a new HNF3 and the HNF1 transcriptional factors in the duck hepatitis B virus enhancer. Virology 213:231-240.
41. Crowther, R. A., N. A. Kiselev, B. Bottcher, J. A. Berriman, G. P. Borisova, V. Ose, and P. Pumpens. 1994. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77:943-950.
42. Dabeva, M. D., G. Alpini, E. Hurston, and D. A. Shafritz. 1993. Models for hepatic progenitor cell activation. Proc. Soc. Exp. Biol. Med. 204:242-252.
43. Dalgleish, A. G., P. C. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-767.
44. Dandri, M., P. Schirmacher, and C. E. Rogler. 1996. Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. J. Virol. 70:5246-5254.
45. Dane, D. S., C. H. Cameron, and M. Briggs. 1970. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet i:695-698.
46. Dejean, A., L. Bougueleret, K. H. Grzeschik, and P. Tiollais. 1986. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature 322:70-72.
47. D'Errico, A., W. F. Grigioni, M. Fiorentino, P. Baccarini, E. Lamas, M. S. De, G. Gozzetti, A. M. Mancini, and C. Brechot. 1994. Expression of insulin-like growth factor II (IGF-II) in human hepatocellular carcinomas: an immunohistochemical study. Pathol. Int. 44:131-137.
48. Di, Q., J. Summers, J. B. Burch, and W. S. Mason. 1997. Major differences between WHV and HBV in the regulation of transcription. Virology 229: 25-35.
49. Dienes, H. P., R. H. Purcell, H. Popper, and A. Ponzetto. 1990. The significance of infections with two types of viral hepatitis demonstrated by histologie features in chimpanzees. J Hepatol. 10:77-84.
50. Dragani, T. A., G. Manenti, H. Farza, G. Della Porta, P. Tiollais, and C. Pourcel. 1990. Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesis. Carcinogenesis 11:953-956.
51. Edman, J. C., P. Gray, P. Valenzuela, L. B. Rall, and W. J. Rutter. 1980. Integration of hepatitis B virus sequences and their expression in a human hepatoma cell line. Nature 286:535-538.
52. Evans, A. A., and W. T. London. 1998. Epidemiology of hepatitis B, p. 107-114. In A. J. Zuckerman and H. C. Thomas (ed.), Viral hepatitis. Harcourt Brace & Co., Ltd., London, United Kingdom.
53. Evans, A. A., A. P. O'Connell, J. C. Pugh, W. S. Mason, F. M. Shen, G. C. Chen, W. Y. Lin, A. Dia, S. M'Boup, B. Drame, and W. T. London. 1998. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma. Cancer Epidemiol. Biomarkers Prev. 7:559-565.
54. Evarts, R. P., P. Nagy, E. Marsden, and S. S. Thorgeirsson. 1987. A precursor product relationship between oval cells and hepatocytes in rat liver. Carcinogenesis 8:1737-1740.
55. Fausto, N. 1990. Hepatocyte differentiation and liver progenitor cells. Curr. Opin. Cell Biol. 2:1036-1042.
56. Fausto, N., J. M. Lemire, and N. Shiojiri. 1993. Cell lineages in hepatic development and the identification of progenitor cells in normal and injured liver. Proc. Soc. Exp. Biol. Med. 214:237-241.
57. Feitelson, M. A., M. Zhu, L. X. Duan, and W. T. London. 1993. Hepatitis B × antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109-1117.
58. Fernholz, D., P. R. Galle, M. Stemler, M. Brunetto, F. Bonino, and H. Will. 1993. Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology 194:137-148.
59. Fourel, G., J. Couturier, Y. Wei, F. Apiou, P. Tiollais, and M. A. Buendia. 1994. Evidence for long-range oncogene activation by hepadnavirus insertion. EMBO J. 13:2526-2534.
60. Fourel, G., C. Trepo, L. Bougueleret, B. Henglein, A. Ponzetto, P. Tiollais, and M. A. Buendia. 1990. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 347:294-298.
61. Ganem, D., J. R. Pollack, and J. Tavis. 1994. Hepatitis B virus reverse transcriptase and its many roles in hepadnaviral genomic replication. Infect. Agents Dis. 3:85-93.
62. Gartner, L. P., and J. L. Hiatt. 1997. Color textbook of histology. The W. B. Saunders Co., Philadelphia. Pa.
63. Gong, S. S., A. D. Jensen, and C. E. Rogler. 1996. Loss and acquisition of duck hepatitis B virus integrations in lineages of LMH-D2 chicken hepatoma cells. J. Virol. 70:2000-2007.
64. Gong, S. S., A. D. Jensen, H. Wang, and C. E. Rogler. 1995. Duck hepatitis B virus integrations in LMH chicken hepatoma cells: identification and characterization of new episomally derived integrations. J. Virol. 69:8102-8108.
65. Gottlieb, T. M., and M. Oren. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287:77-102.
66. Gripon, P., S. J. Le, S. Rumin, and G. C. Guguen. 1995. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 213:292-299.
67. Grisham, J. W. 1962. A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver: autoradiography with thymidine-H3. Cancer Res. 22:842-849.
68. Guidotti, L. G., P. Borrow, M. V. Hobbs, B. Matzke, I. Gresser, M. B. Oldstone, and F. V. Chisari. 1996. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. USA 93:4589-4594.
69. Guidotti, L. G., S. Guilhot, and F. V. Chisari. 1994. Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways. J. Virol. 68:1265-1270.
70. Guidotti, L. G., B. Matzke, H. Schaller, and F. V. Chisari. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.
71. Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
72. Guo, J.-T., and J. C. Pugh. 1997. The topology of the large envelope protein of duck hepatitis B virus suggests a mechanism for membrane translocation during particle morphogenesis. J. Virol. 71:1107-1114.
73. Guo, J.-T., H. Zhou, C. Liu, C. Aldrich, J. Saputelli, T. Whitaker, M. I. Barrasa, W. S. Mason, and C. Seeger. 2000. Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infection. J. Virol. 74:1495-1505.
74. Hadchouel, M., C. Pasquinelli, J. G. Fournier, R. N. Hugon, J. Scotto, O. Bernard, and C. Brechot. 1988. Detection of mononuclear cells expressing hepatitis B virus in peripheral blood from HBsAg positive and negative patients by in situ hybridisation. J. Med. Virol. 24:27-32.
75. Halpern, M. S., J. Egan, W. S. Mason, and J. M. England. 1984. Viral antigen in endocrine cells of the pancreatic islets and adrenal cortex of Pekin ducks infected with duck hepatitis B virus. Virus Res. 1:213-223.
76. Halpern, M. S., J. Egan, S. B. McMahon, and D. L. Ewert. 1985. Duck hepatitis B virus is tropic for exocrine cells of the pancreas. Virology 146:157-161.
77. Halpern, M. S., J. M. England, D. T. Deery, D. J. Petcu, W. S. Mason, and K. L. Molnar-Kimber. 1983. Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virus. Proc. Natl. Acad. Sci. USA 80:4865-4869.
78. Halpern, M. S., W. S. Mason, L. Coates, A. P. O'Connell, and J. M. England. 1987. Humoral immune responsiveness in duck hepatitis B virus-infected ducks. J. Virol. 61:916-920.
79. Havert, M. B., and D. D. Loeb. 1997. cis-acting sequences in addition to donor and acceptor sites are required for template switching during synthesis of plus-strand DNA for duck hepatitis B virus. J. Virol. 71:5336-5344.
80. Haviv, I., M. Shamay, G. Doitsh, and Y. Shaul. 1998. Hepatitis B virus pX targets TFIIB in transcription coactivation. Mol. Cell. Biol. 18:1562-1569.
81. Hayward, W. S., B. G. Neel, and S. M. Astrin. 1981. Activation of a cellular one gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290:475-480.
82. Heermann, K. H., F. Kruse, M. Seifer, and W. H. Gerlich. 1987. Immunogenicity of the gene S and Pre-S domains in hepatitis B virions and HBsAg filaments. Intervirology 28:14-25.
83. Hild, M., O. Weber, and H. Schaller. 1998. Glucagon treatment interferes with an early step of duck hepatitis B virus infection. J. Virol. 72:2600-2606.
84. Hirsch, R. C., J. E. Lavine, L. J. Chang, H. E. Varmus, and D. Ganem. 1990. Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription. Nature 344:552-555.
85. Hohne, M., S. Schaefer, M. Seifer, M. A. Feitelson, D. Paul, and W. H. Gerlich. 1990. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J. 9:1137-1145.
86. Hoofnagle, J., D. Shafritz, and H. Popper. 1987. Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology 7:758-763.
87. Hoofnagle, J. H., and A. M. DiBisceglie. 1997. The treatment of chronic viral hepatitis. N. Engl. J. Med. 336:347-356.
88. Hoofnagle, J. H., T. Michalak, A. Nowoslawski, R. J. Gerety, and L. F. Barker. 1978. Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee. Gastroenterology 74:182-187.
89. Hruska, J. F., D. A. Clayton, J. L. Rubenstein, and W. S. Robinson. 1977. Structure of hepatitis B Dane particle DNA before and after the Dane particle DNA polymerase reaction. J. Virol. 21:666-672.
90. Hsu, I. C., R. A. Metcalf, T. Sun, J. A. Welsh, N. J. Wang, and C. C. Harris. 1991. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-428.
91. Hsu, T., T. Moray, J. Etiemble, A. Louise, C. Trepo, P. Tiollais, and M. Buendia. 1988. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell 55:627-635.
92. Hu, J., and C. Seeger. 1996. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 93:1060-1064.
93. Hu, J., D. O. Toft, and C. Seeger. 1997. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J. 16:59-68.
94. Hu, K. Q., J. M. Vierling, and A. Siddiqui. 1990. Trans-activation of HLA-DR gene by hepatitis B virus X gene product. Proc. Natl. Acad. Sci. USA 87:7140-7144.
95. Huang, M., and J. Summers. 1994. pet, a small sequence distal to the pregenome cap site, is required for expression of the duck hepatitis B virus pregenome. J. Virol. 68:1564-1572.
96. Huovila, A. P., A. M. Eder, and S. D. Fuller. 1992. Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J. Cell Biol. 118: 1305-1320.
97. Ishikawa, T., and D. Ganem. 1995. The pre-S domain of the large viral envelope protein determines host range in avian hepatitis B viruses. Proc. Natl. Acad. Sci. USA. 92:6259-6263.
98. Jilbert, A. R., J. S. Freiman, E. J. Gowans, M. Holmes, Y. E. Cossart, and C. J. Burrell. 1987. Duck hepatitis B virus DNA in liver, spleen, and pancreas: analysis by in situ and Southern blot hybridization. Virology 158:330-338.
99. Jilbert, A. R., D. S. Miller, C. A. Scougall, H. Turnbull, and C. J. Burrell. 1996. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks. Virology 226:338-345.
100. Jilbert, A. R., T.-T. Wu, J. M. England, P. de la M. Hall, N. Z. Carp, A. P. O'Connell, and W. S. Mason. 1992. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J. Virol. 66:1377-1388.
101. Junker-Niepmann, M., R. Bartenschlager, and H. Schaller. 1990. A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J. 9:3389-3396.
102. Kajino, K., A. R. Jilbert, J. Saputelli, C. E. Aldrich, J. Cullen, and W. S. Mason. 1994. Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J. Virol. 68:5792-5803.
103. Kann, M., A. Bischof, and W. H. Gerlich. 1997. In vitro model for the nuclear transport of the hepadnavirus genome. J. Virol. 71:1310-1316.
104. Kann, M., B. Sodeik, A. Vlachou, W. H. Gerlich, and A. Helenius. 1999. Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J. Cell Biol. 145:45-55.
105. Kim, C. M., K. Koike, I. Saito, T. Miyamura, and G. Jay. 1991. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317-320.
106. Kim, H., H. Lee, and Y. Yun. 1998. X-gene product of hepatitis B virus induces apoptosis in liver cells. J. Biol. Chem. 273:381-385.
107. Kinzler, K. W., and B. Vogelstein. 1996. Lessons from hereditary colorectal cancer. Cell 87:159-170.
108. Kock, J., L. Theilmann, P. Galle, and H. J. Schlicht. 1996. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology 23:405-413.
109. Koike, K., K. Moriya, S. Iino, H. Yotsuyanagi, Y. Endo, T. Miyamura, and K. Kurokawa. 1994. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19:810-819.
110. Konig, S., G. Beterams, and M. Nassal. 1998. Mapping of homologous interaction sites in the hepatitis B virus core protein. J. Virol. 72:4997-5005.
111. Korba, B. E., P. J. Cote, M. Shapiro, R. H. Purcell, and J. L. Gerin. 1989. In vitro production of infectious woodchuck hepatitis virus by lipopolysaccharide-stimulated peripheral blood lymphocytes. J. Infect. Dis. 160:572-576.
112. Kuroki, K., R. Cheung, P. L. Marion, and D. Ganem. 1994. A cell surface protein that binds avian hepatitis B virus particles. J. Virol. 68:2091-2096.
113. Kuroki, K., F. Eng, T. Ishikawa, C. Turck, F. Harada, and D. Ganem. 1995. gp180, a host cell glycoprotein that binds duck hepatitis B virus particles, is encoded by a member of the carboxypeptidase gene family. J. Biol. Chem. 270:15022-15028.
114. Kuroki, K., R. Russnak, and D. Ganem. 1989. Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum. Mol. Cell. Biol. 9:4459-4466.
115. Lambert, V., S. Chassot, A. Kay, C. Trepo, and L. Cova. 1991. In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein. Virology 185:446-450.
116. Lambert, V., D. Fernholz, R. Sprengel, I. Fourel, G. Deleage, G. Wildner, C. Peyret, C. Trepo, L. Cova, and H. Will. 1990. Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein. J. Virol. 64:1290-1297.
117. Landers, T. A., H. B. Greenberg, and W. S. Robinson. 1977. Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J. Virol. 23:368-376.
118. Lanford, R. E., L. Notvall, and B. Beames. 1995. Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells. J. Virol. 69:4431-4439.
119. Lee, T. H., S. J. Elledge, and J. S. Butel. 1995. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J. Virol. 69:1107-1114.
120. Lee, T. H., M. J. Finegold, R. F. Shen, J. L. DeMayo, S. L. Woo, and J. S. Butel. 1990. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J. Virol. 64:5939-5947.
121. Lenhoff, R. J., C. A. Luscombe, and J. Summers. 1998. Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus. Virology 251:85-95.
122. Lieberman, H. M., W. W. Tung, and D. A. Shafritz. 1987. Splenic replication of hepatitis B virus in the chimpanzee chronic carrier. J. Med. Virol. 21:347-359.
123. Lien, J. M., C. E. Aldrich, and W. S. Mason. 1986. Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J. Virol. 57:229-236.
124. Lien, J. M., D. J. Petcu, C. E. Aldrich, and W. S. Mason. 1987. Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation. J. Virol. 61:3832-3840.
125. Ling, R., D. Mutimer, M. Ahmed, E. H. Boxall, E. Elias, G. M. Dusheiko, and T. J. Harrison. 1996. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 24:711-713.
126. Liu, C., W. S. Mason, and J. B. Burch. 1994. Identification of factor-binding sites in the duck hepatitis B virus enhancer and in vivo effects of enhancer mutations. J. Virol. 68:2286-2296.
127. Lok, A. S., C. L. Lai, H. T. Chung, J. Y. Lau, E. K. Leung, and L. S. Wong. 1991. Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus-related chronic liver diseases. Hepatology 13:834-837.
128. Lok, A. S., P. C. Wu, C. L. Lai, J. Y. Lau, E. K. Leung, L. S. Wong, O. C. Ma, I. J. Lauder, C. P. Ng, and H. T. Chung. 1992. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 102:2091-2097.
129. London, W. T., A. A. Evans, K. McGlynn, K. Buetow, P. An, L. Gao, E. Lustbader, E. Ross, G. Chen, and F. Shen. 1995. Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology 38:155-161.
130. Luscombe, C., J. Pedersen, E. Uren, and S. Locarnini. 1996. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression. Hepatology 24:766-773.
131. Lutwick, L. I., and W. S. Robinson. 1977. DNA synthesized in the hepatitis B Dane particle DNA polymerase reaction. J. Virol. 21:96-104.
132. MacDonald, R. A. 1960. "Lifespan" of liver cells. Arch. Intern. Med. 107: 335-343.
133. Macrae, D, R., V. Brass, and D. Ganem. 1991. Myristylation of a duck hepatitis B virus envelope protein is essential for infectivity but not for virus assembly. Virology 181:359-363.
134. Maguire, H. F., J. P. Hoeffler, and A. Siddiqui. 1991. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252:842-844.
135. Marion, P. L., L. S. Oshiro, D. C. Regnery, G. H. Scullard, and W. S. Robinson. 1980. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc. Natl. Acad. Sci. USA 77:2941-2945.
136. Marion, P. L., F. H. Salazar, J. J. Alexander, and W. S. Robinson. 1980. State of hepatitis B viral DNA in a human hepatoma cell line. J. Virol. 33:795-806.
137. Mason, W. S., M. S. Halpern, J. M. England, G. Seal, J. Egan, L. Coates, C. Aldrich, and J. Summers. 1983. Experimental transmission of duck hepatitis B virus. Virology 131:375-384.
138. Mason, W. S., G. Seal, and J. Summers. 1980. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J. Virol. 36:829-836.
139. Mason, W. S., T. Zhou, F. Nunes, L. D. Condreay, S. Litwin, and J. Summers. 1998. Antiviral therapy for chronic hepadnavirus infections, p. 177-184. In R. F. Schinazi, J.-P. Sommadossi, and H. C. Thomas (ed.), Therapies for viral hepatitis. International Medical Press, London, United Kingdom.
140. McDougal, J. S., P. J. Maddon, A. G. Dalgleish, P. R. Clapham, D. R. Littman, M. Godfrey, D. E. Maddon, L. Chess, R. A. Weiss, and R. Axel. 1986. The T4 glycoprotein is a cell-surface receptor for the AIDS virus. Cold Spring Harbor Symp. Quant. Biol. 51:703-711.
141. McGlynn, K. A., E. A. Rosvold, E. D. Lustbader, Y. Hu, M. L. Clapper, T. Zhou, C. P. Wild, X. L. Xia, B. A. Baffoe, A. D. Ofori, et al. 1995. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc. Natl. Acad. Sci. USA 92:2384-2387.
142. McMahon, B. J., W. L. Alward, D. B. Hall, W. L. Heyward, T. R. Bender, D. P. Francis, and J. E. Maynard. 1985. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J. Infect. Dis. 151:599-603.
143. Michalak, T. I., I. U. Pardoe, C. S. Coffin, N. D. Churchill, D. S. Freake, P. Smith, and C. L. Trelegan. 1999. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 29:928-938.
144. Milich, D. R., M. K. Chen, J. L. Hughes, and J. E. Jones. 1998. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J. Immunol. 160:2013-2021.
145. Milich, D. R., J. E. Jones, J. L. Hughes, J. Price, A. K. Raney, and A. McLachlan. 1990. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc. Natl. Acad. Sci. USA 87: 6599-6603.
146. Moraleda, G., J. Saputelli, C. E. Aldrich, D. Averett, L. Condreay, and W. S. Mason. 1997. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J. Virol. 71:9392-9399.
147. Negro, F., B. E. Korba, B. Forzani, B. M. Baroudy, T. L. Brown, J. L. Gerin, and A. Ponzetto. 1989. Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks. J. Virol. 63:1612-1618.
148. Netter, H. J., S. Chassot, S. F. Chang, L. Cova, and H. Will. 1997. Sequence heterogeneity of heron hepatitis B virus genomes determined by full-length DNA amplification and direct sequencing reveals novel and unique features. J. Gen. Virol. 78:1707-1718.
149. Newbold, J. E., H. Xin, M. Tencza, G. Sherman, J. Dean, S. Bowden, and S. Locarnini. 1995. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J. Virol. 69:3350-3357.
150. Ng, I. O., L. P. Chung, S. W. Tsang, C. L. Lam, E. C. Lai, S. T. Fan, and M. Ng. 1994. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese. Oncogene 9:985-990.
151. Nicoll, A. J., P. W. Angus, S. T. Chou, C. A. Luscombe, R. A. Smallwood, and S. A. Locarnini. 1997. Demonstration of duck hepatitis B virus in bile duct epithelial cells: implications for pathogencsis and persistent infection. Hepatology 25:463-469.
152. Niesters, H. G., P. Honkoop, E. B. Haagsma, R. A. de Man, S. W. Schalm, and A. D. Osterhaus. 1998. Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment. J. Infect. Dis. 177:1382-1385.
153. Ning, Q., D. Brown, J. Parodo, M. Cattral, R. Gorczynski, E. Cole, L. Fung, J. W. Ding, M. F. Liu, O. Rotstein, M. J. Phillips, and G. Levy. 1998. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J. Immunol. 160:3487-3493.
154. Nowak, M. A., S. Bonhoeffer, A. M. Hill, R. Boehme, H. C. Thomas, and H. McDade. 1996. Viral dynamics in hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 93:4398-4402.
155. Oberhaus, S. M., and J. E. Newbold. 1993. Detection of DNA polymerase activities associated with purified duck hepatitis B virus core particles by using an activity gel assay. J. Virol. 67:6558-6566.
156. Obert, S., B. Zachmann-Brand, E. Deindl, W. Tucker, R. Bartenschlager, and H. Schaller. 1996. A splice hepadnavirus RNA that is essential for virus replication. EMBO J. 15:2565-2574.
157. Oda, T., H. Tsuda, M. Sakamoto, and S. Hirohashi. 1994. Different mutations of the p53 gene in nodule-in-nodule hepatocellular carcinoma as a evidence for multistage progression. Cancer Lett. 83:197-200.
158. Ogata, N., L. Ostberg, P. H. Ehrlich, D. C. Wong, R. H. Miller, and R. H. Purcell. 1993. Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 90:3014-3018.
159. Ogston, C. W., G. J. Jonak, C. E. Rogler, S. M. Astrin, and J. Summers. 1982. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks. Cell 29: 385-394.
160. Ogston, C. W., E. M. Schechter, C. A. Humes, and M. B. Pranikoff. 1989. Extrahepatic replication of woodchuck hepatitis virus in chronic infection. Virology 169:9-14.
161. Ou, J. H., H. Bao, C. Shih, and S. M. Tahara. 1990. Preferred translation of human hepatitis B virus polymerase from core protein- but not from precore protein-specific transcript. J. Virol. 64:4578-4581.
162. Parkin, D. M., P. Pisani, and J. Ferlay. 1999. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80:827-841.
163. Parkin, D. M., P. Pisani, N. Munoz, and J. Ferlay. 1999. The global health burden of infection associated cancers. Cancer Surv. 33:5-33.
164. Payne, G. S., J. M. Bishop, and H. E. Varmus. 1982. Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas. Nature 295:209-214.
165. Perrillo, R. P. 1993. Interferon in the management of chronic hepatitis B. Dig. Dis. Sci. 38:577-593.
166. Persing, D. H., H. E. Varmus, and D. Ganem. 1986. Antibodies to pre-S and X determinants arise during natural infection with ground squirrel hepatitis virus. J. Virol. 60:177-184.
167. Pollack, J. R., and D. Ganem. 1993. An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J. Virol. 67:3254-3263.
168. Pollack, J. R., and D. Ganem. 1994. Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis. J. Virol. 68:5579-5587.
169. Pontisso, P., C. Belluco, R. Bertorelle, L. De Moliner, L. Chieco-Bianchi, D. Nitti, M. Lise, and A. Alberti. 1998. Hepatitis C virus infection associated with human hepatocellular carcinoma: lack of correlation with p53 abnormalities in Caucasian patients. Cancer 83:1489-1494.
170. Pontisso, P., M. C. Poon, P. Tiollais, and C. Brechot. 1984. Detection of hepatitis B virus DNA in mononuclear blood cells. Br. Med. J. Clinical Res. 288:1563-1566.
171. Ponzetto, A., P. J. Cote, E. C. Ford, R. H. Purcell, and J. L. Gerin. 1984. Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus. J. Virol. 52:70-76.
172. Protzer, U., M. Nassal, P.-W. Chiang, M. Kirschfink, and H. Schaller. 1999. Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proc. Natl. Acad. Sci. USA 96:10818-10823.
173. Pugh, J., A. Zweidler, and J. Summers. 1989. Characterization of the major duck hepatitis B virus core particle protein. J. Virol. 63:1371-1376.
174. Pugh, J. C., J. J. Sninsky, J. W. Summers, and E. Schaeffer. 1987. Characterization of a pre-S polypeptide on the surfaces of infectious avian hepadnavirus particles. J. Virol. 61:1384-1390.
175. Rhim, J. A., E. P. Sandgren, J. L. Degen, R. D. Palmiter, and R. L. Brinster. 1994. Replacement of diseased mouse liver by hepatic cell regeneration. Science 263:1149-1152.
176. Rogler, C. E. 1991. Cellular and molecular mechanisms of hepatocarcinogenesis associated with hepadnavirus infection. Curr. Top. Microbiol. Immunol. 168:103-140.
177. Rogler, C. E., and J. Summers. 1982. Novel forms of woodchuck hepatitis virus DNA isolated from chronically infected woodchuck liver nuclei. J. Virol. 44:852-863.
178. Schaller, H., and M. Fischer. 1991. Transcriptional control of hepadnavirus gene expression. Curr. Top. Microbiol. Immunol. 168:21-39.
179. Seeger, C., D. Ganem, and H. E. Varmus. 1986. Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science 232:477-484.
180. Seeger, C., D. Ganem, and H. E. Varmus. 1984. The cloned genome of ground squirrel hepatitis virus is infectious in the animal. Proc. Natl. Acad. Sci. USA 81:5849-5852.
181. Seeger, C., and W. S. Mason. 1999. Chronic hepadnavirus infections of the woodchuck and duck, p. 607-621. In R. Ahmed and I. Chen (ed.), Persistent viral infection. John Wiley & Sons, Inc., New York, N.Y.
182. Seeger, C., and W. S. Mason. 1996. Replication of the hepatitis virus genome, p. 815-831. In M. L. DePamphilis (ed.), DNA replication in eukaryotic cells. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
183. Seifer, M., M. Hohne, S. Schaefer, and W. H. Gerlich. 1991. In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. J. Hepatol. 13:S61-S65.
184. Shaul, Y. 1992. Regulation of hepadnavirus transcription, p. 193-211. In A. McLachlan (ed.), Molecular biology of the hepatitis B virus. CRC Press, Inc., Boca Raton, Fla.
185. Sheu, J. C., G. T. Huang, P. H. Lee, J. C. Chung, H. C. Chou, M. Y. Lai, J. T. Wang, H. S. Lee, L. N. Shih, P. M. Yang, et al. 1992. Mutation of p53 gene in hepatocellular carcinoma in Taiwan. Cancer Res. 52:6098-6100.
186. Shimazu, T., S. Takada, Y. Ueno, Y. Hayashi, and K. Koike. 1998. Post-transcriptional control of the level of mRNA by hepatitis B virus X gene in the transient expression system using human hepatic cells. Genes Cells 3:477-484.
187. Shimoda, T., T. Shikata, T. Karasawa, S. Tsukagoshi, M. Yoshimura, and I. Sakurai. 1981. Light microscopic localization of hepatitis B virus antigens in human pancreas. Gastroenterology 81:998-1005.
188. Shiojiri, N. 1981. Enzymo- and immunocytochemical analyses of the differentiation of liver cells in the prenatal mouse. J. Embryol. Exp. Morphol. 62:139-152.
189. Shiojiri, N. 1984. The origin of intrahepatic bile duct cells in the mouse. J. Embryol. Exp. Morphol. 79:25-39.
190. Sirma, H., R. Weil, O. Rosmorduc, S. Urban, A. Israel, D. Kremsdorf, and C. Brechot. 1998. Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome. Oncogene 16:2051-2063.
191. Slagle, B. L., T. H. Lee, D. Medina, M. J. Finegold, and J. S. Butel. 1996. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol. Carcinog. 15:261-269.
192. Spandau, D. F., and C. H. Lee. 1988. trans-activation of viral enhancers by the hepatitis B virus X protein. J. Virol. 62:427-434.
193. Sprengel, R., E. F. Kaleta, and H. Will. 1988. Isolation and characterization of a hepatitis B virus endemic in herons. J. Virol. 62:932-937.
194. Staprans, S., D. D. Loeb, and D. Ganem. 1991. Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J. Virol. 65:1255-1262.
195. Stevens, C. E., R. P. Beasley, J. Tsui, and W. C. Lee. 1975. Vertical transmission of hepatitis B antigen in Taiwan. N. Engl. J. Med. 292:771-774.
196. Stevens, C. E., P. T. Toy, M. J. Tong, P. E. Taylor, G. N. Vyas, P. V. Nair, M. Gudavalli, and S. Krugman. 1985. Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization. JAMA 253:1740-1745.
197. Stoll-Becker, S., R. Repp, D. Glebe, S. Schaefer, J. Kreuder, M. Kann, F. Lampert, and W. H. Gerlich. 1997. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J. Virol. 71:5399-5407.
198. Summers, J., and W. S. Mason. 1982. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403-415.
199. Summers, J., A. O'Connell, and I. Millman. 1975. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc. Natl. Acad. Sci. USA 72:4597-4601.
200. Summers, J., P. M. Smith, and A. L. Horwich. 1990. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J. Virol. 64:2819-2824.
201. Summers, J., P. M. Smith, M. J. Huang, and M. S. Yu. 1991. Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J. Virol. 65:1310-1317.
202. Summers, J., J. Smolec, and R. Snyder. 1978. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. USA 75:4533-4537.
203. Tagawa, M., M. Omata, and K. Okuda. 1986. Appearance of viral RNA transcripts in the early stage of duck hepatitis B virus infection. Virology 152:477-482.
204. Tagawa, M., W. S. Robinson, and P. L. Marion. 1987. Duck hepatitis B virus replicates in the yolk sac of developing embryos. J. Virol. 61:2273-2279.
205. Takada, S., and K. Koike. 1990. X protein of hepatitis B virus resembles a serine protease inhibitor. Jpn. J. Cancer Res. 81:1191-1194.
206. Takada, S., N. Tsuchida, M. Kobayashi, and K. Koike. 1995. Disruption of the function of tumor-suppressor gene p53 by the hepatitis B virus X protein and hepatocarcinogenesis. J. Cancer Res. Clin. Oncol. 121:593-601.
207. Tavis, J. E., and D. Ganem. 1993. Expression of functional hepatitis B virus polymerase in yeast reveals it to be the sole viral protein required for correct initiation of reverse transcription. Proc. Natl. Acad. Sci. USA 90: 4107-4111.
208. Tennant, B. C., N. Mrosovsky, K. McLean, P. J. Cote, B. E. Korba, R. E. Engle, J. L. Gerin, J. Wright, G. R. Michener, E. Uhl, et al. 1991. Hepatocellular carcinoma in Richardson's ground squirrels (Spermophilus richardsonii): evidence for association with hepatitis B-like virus infection. Hepatology 13:1215-1221.
209. Terradillos, O., O. Billet, C. A. Renard, R. Levy, T. Molina, P. Briand, and M. A. Buendia. 1997. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 14:395-404.
210. Testut, P., C. A. Renard, O. Terradillos, T. L. Vitvitski, F. Tekaia, C. Degott, J. Blake, B. Boyer, and M. A. Buendia. 1996. A new hepadnavirus endemic in arctic ground squirrels in Alaska. J. Virol. 70:4210-4219.
211. Thorgeirsson, S. S. 1996. Hepatic stem cells in liver regeneration. FASEB J. 10:1249-1256.
212. Thorgeirsson, S. S., R. P. Evarts, H. C. Bisgaard, K. Fujio, and Z. Hu. 1993. Hepatic stem cell compartment: activation and lineage commitment. Proc. Soc. Exp. Biol. Med. 204:253-260.
213. Tipples, G. A., M. M. Ma, K. P. Fischer, V. G. Bain, N. M. Kneteman, and D. L. J. Tyrrell. 1996. Mutation in HBV DNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24:714-717.
214. Tong, S., J. Li, and J. R. Wands. 1995. Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection. J. Virol. 69:7106-7112.
215. Tsiquaye, K. N., T. J. Harrison, B. Portmann, S. Hu, and A. J. Zuckerman. 1984. Acute hepatitis A infection in hepatitis B chimpanzee carriers. Hepatology 4:504-509.
216. Tsui, L. V., L. G. Guidotti, T. Ishikawa, and F. V. Chisari. 1995. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc. Natl. Acad. Sci. USA 92:12398-12402.
217. Tuttleman, J. S., C. Pourcel, and J. Summers. 1986. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47:451-460.
218. Twu, J. S., K. Chu, and W. S. Robinson. 1989. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 86:5168-5172.
219. Twu, J. S., and R. H. Schloemer. 1987. Transcriptional trans-activating function of hepatitis B virus. J. Virol. 61:3448-3453.
220. Ueda, K., and D. Ganem. 1996. Apoptosis is induced by N-myc expression in hepatocytes, a frequent event in hepadnavirus oncogenesis, and is blocked by insulin-like growth factor II. J. Virol. 70:1375-1383.
221. Urban, M. K., A. P. O'Connell, and W. T. London. 1985. Sequence of events in natural infection of Pekin duck embryos with duck hepatitis B virus. J. Virol. 55:16-22.
222. Urban, S., K. M. Breiner, F. Fehler, U. Klingmuller, and H. Schaller. 1998. Avian hepatitis B virus infection is initiated by the interaction of a distinct pre-S subdomain with the cellular receptor gp180. J. Virol. 72:8089-8097.
223. Vitvitski, T. L., A. Kay, C. Pichoud, P. Chevallier, D. S. de, B. M. Shamoon, E. Mandart, C. Trepo, and F. Galibert. 1990. Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection. Hepatology 12: 1278-1283.
224. Wang, G. H., and C. Seeger. 1993. Novel mechanism for reverse transcription in hepatitis B viruses. J. Virol. 67:6507-6512.
225. Wang, G. H., and C. Seeger. 1992. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71:663-670.
226. Wang, G. H., F. Zoulim, E. H. Leber, J. Kitson, and C. Seeger. 1994. Role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses. J. Virol. 68:8437-8442.
227. Wang, J., X. Chenivesse, B. Henglein, and C. Brechet. 1990. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343:555-557.
228. Wang, J., F. Zindy, X. Chenivesse, E. Lamas, B. Henglein, and C. Brechot. 1992. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene 7:1653-1656.
229. Wang, X. W., K. Forrester, H. Yeh, M. A. Feitelson, J. R. Gu, and C. C. Harris. 1994. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. USA 91:2230-2234.
230. Weber, M., V. Bronsema, H. Bartos, A. Bosserhoff, R. Bartenschlager, and H. Schaller. 1994. Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J. Virol. 68:2994-2999.
231. Wei, Y., J. E. Tavis, and D. Ganem. 1996. Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses. J. Virol. 70:6455-6458.
232. Wei, Y., B. Tennant, and D. Ganem. 1998. In vivo effects of mutations in woodchuck hepatitis virus enhancer II. J. Virol. 72:6608-6613.
233. Will, H., R. Cattaneo, H. Koch, G. Darai, H. Schaller, H. Schellekens, P. van Eerd, and F. Deinhardt. 1982. Cloned HBV DNA causes hepatitis in chimpanzees. Nature 299:740-742.
234. Wong, D. K., A. M. Cheung, K. O'Rourke, C. D. Naylor, A. S. Detsky, and J. Heathcote. 1993. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann. Intern. Med. 119:312-323.
235. Wynne, S. A., R. A. Crowther, and A. G. Leslie. 1999. The crystal structure of the human hepatitis B virus capsid. Mol. Cell. 3:771-780.
236. Xiong, X., C. Flores, H. Yang, J. J. Toole, and C. S. Gibbs. 1998. Mutations in hepatitis B virus DNA polymerase associated with resistance to lamivudine do not confer resistance to Adefovir in vitro. Hepatology 28:1669-1673.
237. Yaginuma, K., Y. Shirakata, M. Kobayashi, and K. Koike. 1987. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc. Natl. Acad. Sci. USA 84:2678-2682.
238. Yang, D., E. Alt, and C. E. Rogler. 1993. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers. Cancer Res. 53:2020-2027.
239. Yang, D., R. Paris, D. Hixson, S. Affigne, and C. E. Rogler. 1996. Insulin-like growth factor II blocks apoptosis of N-myc2-expressing woodchuck liver epithelial cells. J. Virol. 70:6260-6268.
240. Yang, D. Y., and C. E. Rogler. 1991. Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunocytochemistry. Carcinogenesis 12:1893-1901.
241. Yang, W., W. S. Mason, and J. Summers. 1996. Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver. J. Virol. 70:4567-4575.
242. Yang, W., and J. Summers. 1995. Illegitimate replication of linear hepadnavirus DNA through nonhomologous recombination. J. Virol. 69:4029-4036.
243. Yoffe, B., C. A. Noonan, J. L. Melnick, and F. B. Hollinger. 1986. Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA. J. Infect. Dis. 153:471-477.
244. Young, J. A., P. Bates, and H. E. Varmus. 1993. Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses. J. Virol. 67:1811-1816.
245. Yu, M., and J. Summers. 1994. Multiple functions of capsid protein phosphorylation in duck hepatitis B virus replication. J. Virol. 68:4341-4348.
246. Yu, M., and J. Summers. 1994. Phosphorylation of the duck hepatitis B virus capsid protein associated with conformational changes in the C terminus. J. Virol. 68:2965-2969.
247. Yuasa, S., R. C. Cheung, Q. Pham, W. S. Robinson, and P. L. Marion. 1991. Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide. Virology 181:14-21.
248. Zachoval, R., M. Roggendorf, and F. Deinhardt. 1983. Hepatitis A infection in chronic carriers of hepatitis B virus. Hepatology 3:528-531.
249. Zanta, M. A., P. Belguise-Valladier, and J. P. Behr. 1999. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. USA 96:91-96.
250. Zhang, Y.-Y., and J. Summers. 1999. Selective advantage of a precoreminus mutant in mixed infections with duck hepatitis B virus. J. Virol. 73:3616-3622.
251. Zhou, D. X., A. Taraboulos, J. H. Ou, and T. S. Yen. 1990. Activation of class I major histocompatibility complex gene expression by hepatitis B virus. J. Virol. 64:4025-4028.
252. Zlotnick, A., N. Cheng, J. F. Conway, F. P. Booy, A. C. Steven, S. J. Stahl, and P. T. Wingfleld. 1996. Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry 35:7412-7421.
253. Zlotnick, A., S. J. Stahl, P. T. Wingfleld, J. F. Conway, N. Cheng, and A. C. Steven. 1998. Shared motifs of the capsid proteins of hepadnaviruses and retroviruses suggest a common evolutionary origin. FEBS Lett. 431:301-304.
254. Zoulim, F., J. Saputelli, and C. Seeger. 1994. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68:2026-2030.
255. Zoulim, F., and C. Seeger. 1994. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J. Virol. 68:6-13.